Skip to main content

Table 4 Muscle relaxant recovery profile in both groups for patients who received reversal within less and more than 15 minutes after the last dose of rocuronium

From: Half-dose sugammadex with neostigmine versus full-dose sugammadex for reversal of rocuronium in laparoscopic bariatric surgery

Variable NS group (n = 12) S group (n = 13) 95% CI of mean difference P value
Anesthesia Duration
< 15 minutes 108.25±12.66 115.43±26.12 -24.3 , 9.9 .39a
>15minutes 118.38±10.13 126.58±31.82 -27.4,11 .39a
Surgery Duration
< 15 minutes 100.8 ± 12.56 108.6 ± 26.44 -25.1, 9.6 0.36a
>15minutes 112 ± 10.6 119.6 ± 32.5 -27.2, 12.1 0.41a
Et- isoflurane Conc. at the end of surgery
< 15 minutes 1.34±.32 1.53±.28 -0.44,0.05 0.12a
>15minutes 1.49±0.29 1.28±0.36 -0.06 , 0.5 0.12a
Total dose (mg)
< 15 minutes 82.5±9.89 91.92±26.89 -26.4,7.6 0.26a
>15minutes 93.08±9.9 88.33±16.97 -7.1,16.6 0.41a
D. R - 90% TOF (seconds)
< 15 minutes 385.1 ± 74.9 307.1 ± 97.1 5.8 , 150.1 0.04*,a
>15minutes 287 ± 98.9 280 ± 94.7 -73.2, 87.3 0.89a
D. R-Extubation (seconds)
< 15 minutes 472.0 ±78.6 384.7 ± 99.0 12.9, 161.7 0.04*,a
>15minutes 384 ± 98.5 366.6 ± 83.3 -58.5 , 93.1 0.65a
  1. Data are expressed as mean and standard deviation. 95% CI: 95% confidence interval. aMann Whitney independent samples test. *p value is significant when ˂ 0.05. Abbreviations: group (NS) half dose sugammadex plus neostigmine, group (S) full dose sugammadex group, Et End tidal, Conc. Concentration, D.R - 90% TOF duration (seconds) between IV reversal and 90% TOF, D.R-Extubation Duration between IV reversal and tracheal extubation
\